Obstetric and pediatric clinical pharmacology

Research Research programs Obstetric and pediatric clinical pharmacology

Our mission

We aim to develop a multidisciplinary platform to support and improve evidence-based pharmacotherapy in pregnancy, lactation and pediatrics.

Goals

See some of the most important goals for this research program.

Listen

Goals

To develop, refine, and implement methodologies to study pharmacology, toxicology, and pharmacotherapy for these groups.
To reduce the knowledge gap on pharmacology, toxicology, and pharmacotherapy for selected diseases and medications by adding evidence ranging from preclinical to post-marketing studies.
To implement new dosing and treatment knowledge in clinical guidelines for pharmacotherapy.
To facilitate and promote a normative framework for responsible innovation and implementation of pharmacotherapy in these groups.
To educate healthcare workers on pharmacological and safety issues in these special and vulnerable populations.

Research groups contributing to this research program

Clinical pharmacy

David Burger's research group uses clinical pharmacology to improve antiviral therapy globally. We focus mainly on HIV. Our main areas of interest are drug-drug interactions, pediatric pharmacology and therapeutic drug monitoring.

Internal medicine

Saskia Middeldorp's research group focuses on venous thromboembolism, and performs clinical and translational research on hereditary and acquired thrombophilia, women’s issues in thrombosis, and the evaluation of new anticoagulants and antidotes.

Obstetrics

Marc Spaanderman's research group aims on improving and maintaining health before, during and after pregnancy by individualized interventions are our research targets.

Spokesperson(s) for this research program

Spokesperson

dr. Marleen van Gelder

contact form